(Q44755820)

6 December 2017

HMG CoA reductase inhibitors and the risk of venous thrombosis among postmenopausal women (English)

1 reference

6 December 2017

0 references

5

Psaty BM

1 reference

6 December 2017

4

Heckbert SR

1 reference

6 December 2017

Doggen CJ

1

1 reference

PubMed ID

15099273

6 December 2017

Lemaitre RN

series ordinal

2

1 reference

PubMed ID

15099273

6 December 2017

Smith NL

series ordinal

3

1 reference

6 December 2017

1 May 2004

1 reference

Journal of Thrombosis and Haemostasis

6 December 2017

1 reference

6 December 2017

2

1 reference

6 December 2017

5

1 reference

6 December 2017

700-701

1 reference

Dyslipidemia, statins, and venous thromboembolism: a potential risk factor and a potential treatment

6 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00696.X

Use of statins and the subsequent development of deep vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00696.X

New insights into the pharmacodynamic and pharmacokinetic properties of statins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00696.X

Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00696.X

Vastatins Inhibit Tissue Factor in Cultured Human Macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00696.X

10.1111/J.1538-7836.2004.00696.X

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference

PubMed ID

15099273